A real-world cost-effectiveness study of vancomycin versus linezolid for the treatment of late-onset neonatal sepsis in the NICU in China.

Autor: Xie, Linjun¹ (AUTHOR), Ding, Leyun¹ (AUTHOR), Tang, Lian¹ (AUTHOR), Yang, Zuming² (AUTHOR), Wu, Dan¹ (AUTHOR), Wang, Wenjuan³ (AUTHOR), Mao, Juehui⁴ (AUTHOR), Shi, Lu¹ (AUTHOR), Liu, Chun¹ (AUTHOR), Duan, Lufen¹ (AUTHOR), Xu, Jinhui¹ (AUTHOR), Zhou, Qin¹ (AUTHOR) zhouyx1223@yeah.net, Sun, Jiantong¹ (AUTHOR) 18915591290@163.com, Ding, Xinyuan¹ (AUTHOR) aladdine@163.com

Publikováno v: BMC Health Services Research. 7/19/2023, Vol. 23 Issue 1, p1-9. 9p. 2 Diagrams, 3 Charts, 2 Graphs.

Additional file 2 of A real-world cost-effectiveness study of vancomycin versus linezolid for the treatment of late-onset neonatal sepsis in the NICU in China

Autor: Xie, Linjun, Ding, Leyun, Tang, Lian, Yang, Zuming, Wu, Dan, Wang, Wenjuan, Mao, Juehui, Shi, Lu, Liu, Chun, Duan, Lufen, Xu, Jinhui, Zhou, Qin, Sun, Jiantong, Ding, Xinyuan

Additional file 2: Table S2. Basic data comparison of the vancomycin group versus the linezolid group of patients with neonatal sepsis in our hospital.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7093df0ada4fcbc3e11f4df48af8fe4d

Additional file 5 of A real-world cost-effectiveness study of vancomycin versus linezolid for the treatment of late-onset neonatal sepsis in the NICU in China

Autor: Xie, Linjun, Ding, Leyun, Tang, Lian, Yang, Zuming, Wu, Dan, Wang, Wenjuan, Mao, Juehui, Shi, Lu, Liu, Chun, Duan, Lufen, Xu, Jinhui, Zhou, Qin, Sun, Jiantong, Ding, Xinyuan

Additional file 5: Table S5. Base-case cost for the decision analytic model in 2020.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::731c362abb85a9484ebd6d017a3cc7cc

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.